SITKA BIOPHARMA
Sitka Biopharma is a preclinical biotechnology company focused on developing its breakthrough nanoparticle platform technology to increase absorption of drugs in difficult-to-penetrate tissues. Initially targeting oncology indications, we are developing our lead candidate (STK-01) to address the absorption challenge of intravesical chemotherapy for bladder cancer, and later intraperitoneal delivery for ovarian cancer. Their nanoparticle platform technology is highly versatile, offers unique b... enefits over other nano-delivery systems, and is particularly well-suited for treating relatively localized diseases where local administration of the therapeutic is possible but is currently ineffective or unsafe. Bladder cancer was chosen for their lead program because it is characterized by therapies that exhibit limited uptake and efficacy, or are associated with significant tolerability issues and side effects. Sitkaโs novel product (STK-01) is designed to overcome these issues and improve treatment outcomes by delivering a much higher concentration of the chemotherapeutic docetaxel into the bladder wall.
SITKA BIOPHARMA
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2013-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.sitkabiopharma.com
Total Employee:
1+
Status:
Active
Total Funding:
5.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Nginx Google Maps DigiCert SSL Google Adsense AdBlock Acceptable Ads Google Adsense For Domains
Current Advisors List
Current Employees Featured
Founder
Investors List
Centre for Drug Research and Development
Centre for Drug Research and Development investment in Venture Round - Sitka Biopharma
Quark Venture
Quark Venture investment in Venture Round - Sitka Biopharma
GF Securities
GF Securities investment in Venture Round - Sitka Biopharma
Quark Venture
Quark Venture investment in Seed Round - Sitka Biopharma
Quark Venture
Quark Venture investment in Seed Round - Sitka Biopharma
Accel-Rx Health Sciences Accelerator
Accel-Rx Health Sciences Accelerator investment in Pre Seed Round - Sitka Biopharma
Official Site Inspections
http://www.sitkabiopharma.com Semrush global rank: 5.37 M Semrush visits lastest month: 1.56 K
- Host name: ec2-54-67-42-145.us-west-1.compute.amazonaws.com
- IP address: 54.67.42.145
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141